Artra Group
6029
Daiwa Cycle
5888
Asiro
7378
Business Coach
9562
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||
Cash from operating activities | 111.68%48.69B | -224.48%-416.82B | 35.82%334.85B | 282.95%246.53B | -148.30%-134.75B | -54.27B |
Net profit before non-cash adjustment | 16.27%10.45B | 139.86%8.99B | -31.01%3.75B | -16.95%5.43B | -87.90%6.54B | --54.01B |
Total adjustment of non-cash items | -8.84%-29.89B | 6.00%-27.46B | 23.87%-29.21B | -27.75%-38.37B | 62.31%-30.04B | ---79.68B |
-Depreciation and amortization | -5.16%4.41B | -12.19%4.65B | 32.52%5.29B | 15.60%3.99B | 6.73%3.46B | --3.24B |
-Assets reserve and write-off | -46.01%318M | -42.08%589M | -3.69%1.02B | 1,930.77%1.06B | -61.19%52M | --134M |
-Other restructuring costs | ---- | ---- | ---- | ---- | ---- | ---46.36B |
-Disposal profit | -125.65%-862M | 78.31%-382M | 81.13%-1.76B | -742.26%-9.33B | 201.82%1.45B | ---1.43B |
-Net exchange gains and losses | ---- | ---- | ---- | ---2M | --0 | --0 |
-Other non-cash items | -4.44%-33.75B | 4.29%-32.31B | 0.95%-33.76B | 2.60%-34.09B | 0.77%-35B | ---35.27B |
Changes in working capital | 117.10%68.13B | -210.56%-398.35B | 28.93%360.31B | 351.20%279.47B | -289.01%-111.26B | ---28.6B |
-Change in receivables | -713.19%-1.12B | -86.95%182M | 40.06%1.4B | 126.10%996M | 8.29%-3.82B | ---4.16B |
-Change in loans | 101.36%6.05B | -223.34%-444.95B | 732.97%360.75B | 349.19%43.31B | 75.74%-17.38B | ---71.63B |
-Change in financial assets | 461.90%472M | -74.31%84M | 43.42%327M | 128.00%228M | 433.33%100M | ---30M |
-Provision for loans, leases and other losses | -364.46%-3.02B | 68.18%-650M | -132.42%-2.04B | 515.63%6.3B | -168.32%-1.52B | ---565M |
-Change in deposits by banks and customers | 35.38%62.55B | 3,696.47%46.2B | -99.47%1.22B | 518.35%229.04B | -257.72%-54.75B | --34.71B |
-Change in financial liabilities | ---- | ---- | ---- | ---- | -354.16%-33.06B | --13.01B |
-Changes in other current assets | 297.51%3.2B | 161.19%804M | -218.16%-1.31B | 50.30%-413M | -673.10%-831M | --145M |
-Changes in other current liabilities | 103.85%1M | -36.84%-26M | -246.15%-19M | 360.00%13M | 93.59%-5M | ---78M |
Dividends paid (cash flow from operating activities) | ||||||
Dividends received (cash flow from operating activities) | ||||||
Interest paid (cash flow from operating activities) | -4.05%-488M | 26.72%-469M | 37.50%-640M | 30.53%-1.02B | 17.93%-1.47B | -1.8B |
Interest received (cash flow from operating activities) | 0.20%33.28B | -5.31%33.21B | -4.03%35.07B | -5.36%36.54B | -3.54%38.61B | 40.03B |
Tax refund paid | -255.45%-1.9B | 122.10%1.22B | -28.66%-5.53B | -50.91%-4.3B | -25.60%-2.85B | -2.27B |
Other operating cash inflow (outflow) | -3,246.10%-12.49B | -96.44%397M | 232.00%11.15B | 13.82%-8.45B | -205.39%-9.8B | -3.21B |
Operating cash flow | 117.54%67.09B | -202.02%-382.47B | 39.21%374.9B | 344.24%269.31B | -412.46%-110.27B | ---21.52B |
Investing cash flow | ||||||
Net PPE purchase and sale | -280.25%-1B | 136.17%557M | -154.96%-1.54B | 257.15%2.8B | -2.47%-1.78B | ---1.74B |
Net intangibles purchase and sale | -3.68%-563M | 83.31%-543M | 17.72%-3.25B | 13.72%-3.96B | -146.58%-4.58B | ---1.86B |
Net investment property transactions | 85.72%-14.78B | -862,325.00%-103.49B | -100.02%-12M | -29.04%54.31B | 477.85%76.53B | --13.24B |
Net changes in other investments | 198.20%39.73B | -16,619.01%-40.46B | 15.68%-242M | -226.14%-287M | -4,300.00%-88M | ---2M |
Investing cash flow | 116.25%23.39B | -2,751.37%-143.94B | -109.55%-5.05B | -24.56%52.87B | 626.69%70.08B | --9.64B |
Financing cash flow | ||||||
Net common stock issuance | 99.99%-4M | -1,511,050.00%-30.22B | 0.00%-2M | 33.33%-2M | 99.08%-3M | ---325M |
Increase or decrease of lease financing | 83.33%-1M | 66.67%-6M | ---18M | --0 | ---- | ---- |
Cash dividends paid | 8.41%-1.88B | 7.72%-2.06B | -0.13%-2.23B | -0.04%-2.23B | 20.43%-2.22B | ---2.8B |
Cash dividends for minorities | --0 | --0 | ---4M | --0 | 85.71%-1M | ---7M |
Net other fund-raising expenses | -19,850.00%-399M | 0.00%-2M | -100.00%-2M | 99.99%-1M | -355.58%-7.92B | ---1.74B |
Financing cash flow | 92.92%-2.29B | -1,332.43%-32.29B | -1.17%-2.25B | 78.04%-2.23B | -108.55%-10.15B | ---4.87B |
Net cash flow | ||||||
Beginning cash position | -62.29%338.22B | 69.45%896.91B | 152.82%529.31B | -19.38%209.36B | 103.09%259.7B | --127.88B |
Current changes in cash | 115.79%88.19B | -251.98%-558.69B | 14.89%367.6B | 735.62%319.95B | -200.71%-50.34B | ---16.74B |
Effect of exchange rate changes | ---- | ---- | ---- | --2M | --0 | --0 |
Cash adjustments other than cash changes | ---- | ---2M | ---- | ---- | ---- | --148.56B |
End cash Position | 26.08%426.41B | -62.29%338.22B | 69.45%896.91B | 152.82%529.31B | -19.38%209.36B | --259.7B |
Free cash flow | 116.40%63.1B | -204.11%-384.83B | 41.09%369.63B | 323.27%261.97B | -364.65%-117.33B | ---25.25B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |